HUBS vs MREO · P/E 96, rev $1.79B vs $48.7M cap
HubSpot Inc (HUBS) versus Mereo BioPharma Group PLC ADR (MREO) — a side-by-side from cached financials, not a winner call.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
HUBS currently screens at market cap $9.36B and trailing P/E 96.2. MREO currently screens at market cap $48.7M.
Not investment advice. Open the HUBS and MREO stock pages for the full models.
Not investment advice.